Skip to main content
Clinical Trials/NCT06282367
NCT06282367CompletedNot Applicable

Novel Regimen for Colonoscopy Bowel Preparation With Oral Lactulose: A Prospective Comparative Study

Josue Aliaga1 site in 1 country222 target enrollmentStarted: July 1, 2021Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
222
Locations
1
Primary Endpoint
Degree of bowel cleansing using the Boston score

Study Overview

Brief Summary

Background and Aims: The quality of colonoscopy is critically influenced by bowel preparation. Polyethylene glycol (PEG) is considered the gold standard regimen for bowel preparation, however due to the necessity of large volume of patient's tolerance is impaired, especially in the elderly population. Lactulose has been adopted in a few centers as a novel alternative for colonoscopy preparation. This study aimed to investigate the efficacy-safety profile of a lactulose-based bowel preparation in comparison to PEG for colonoscopy.

Methods: Prospective non-blinded comparative study, developed in two tertiary centers from July 2021 to April 2023. Outpatients undergoing colonoscopy were randomly divided into 2 groups: Group 1 (111 patients): PEG and Group 2 (111 patients): Lactulose. The following clinical outcomes were assessed for each group: degree of bowel clearance using the Boston Score, colorectal polyp detection rate, adenoma detection rate, tolerability and side effects.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients age ≥ 18 years
  • Colorectal cancer screening
  • Lower gastrointestinal bleeding
  • Iron deficiency anemia
  • Chronic diarrhea

Exclusion Criteria

  • Patients with previous colorectal surgery
  • Emergency colonoscopies
  • Use of any other scheme or substance for bowel preparation different from those studied
  • Incomplete information
  • Clinical conditions considered unsuitable for sedation or colonoscopy

Outcomes

Primary Outcomes

Degree of bowel cleansing using the Boston score

Time Frame: 21 month

minimum value: 0 (worse outcome: inadequate bowel preparation); maximum value: 9 (better outcome: adequate bowel preparation)

Secondary Outcomes

  • adenomas detection rate(21 months)

Investigators

Sponsor
Josue Aliaga
Sponsor Class
Other Gov
Responsible Party
Sponsor Investigator
Principal Investigator

Josue Aliaga

Gastroenterologist

Hospital Jose Agurto Tello

Study Sites (1)

Loading locations...

Similar Trials

Bowel Preparation for Colonoscopy With... | Clinical Trial